A method for measuring fluorescence in anchored monolayers of human endothelial cells is described and used to demonstrate changes in the cytosolic free-calcium concentration ([Ca2+I¢) 
Introduction
Thrombin has a variety of effects on endothelium including stimulation of prostacyclin (PGI2)' and platelet-activating factor (PAF) synthesis (1, 2) , cell retraction (3), mitogenesis (4) , and secretion ofadenine nucleotides (5) , von Willebrand factor(vWF) (6) and "'endothelium-derived relaxant factor" (7) . Because many effects of thrombin can be mimicked by calcium ionophore, a rise in cytosolic calcium has been suspected to be an important triggering event in the endothelium's response to this enzyme.
Histamine has also been shown to elicit multiple responses from endothelial cells, including PGI2 and PAF synthesis (8) , disassembly of actin filaments (9) , and cell retraction (10) (11) (12) . Histamine-induced permeability changes and PGI2 and PAF synthesis are inhibited by HI-receptor antagonists, suggesting the existence of functional human endothelial H1 receptors. On the other hand, both HI-and H2-specific agonists have been shown to bind to endothelium in the mouse (13) . Nevertheless, intracellular events triggered by binding of histamine to its receptor, including possible coupling to cytosolic Ca2" transients, have not been examined for endothelial histamine receptors.
Fluorescent calcium-sensitive intracellular probes have enabled receptor-mediated cytosolic calcium transients to be examined in a variety of cells (14) (15) (16) (17) (18) (19) (20) . However, obtaining these measurements from anchorage-dependent cells has usually required that the cells be physically or enzymatically detached from their culture surface to form a suspension suitable for spectrofluorometry. For example, trypsinization has recently been used to form suspensions of rat smooth muscle cells (19) and renal tubular cells (20) for study using quin2 and fura-2. Such procedures alter the normal cell surface, abrogate cell polarity, and destroy normal intercellular junctions; results must therefore be interpreted cautiously with respect to conditions obtaining in anchorage-dependent cells in their characteristic attached state. Our interest in the role of cytosolic calcium in the endothelial responses to thrombin and histamine led us to develop a method using indo-for observing changes in intracellular calcium within human endothelial cells maintained as a confluent monolayer on microcarriers. Cell culture. Human endothelial cells were obtained from umbilical veins by treatment with 0.1% collagenase. Cells from one cord were pelleted and resuspended in 5 ml of Medium 199 with 20% fetal bovine serum, 10 jig/ml endothelial cell growth supplement, 90 ;g/ml porcine heparin, 100 U/ml penicillin, 100 Ag/ml streptomycin, bovine insulin 5 ,gg/ml, human transferrin 5 ;g/ml, and sodium selenite 5 ng/ml. The cell suspension was added to 1.5 ml of a suspension of Cytodex 3 microcarriers (Pharmacia Fine Chemicals, Piscataway, NJ), prepared according to the manufacturer's instructions (1 g ofdry beads/100 ml) and preincubated in culture medium. Cells were grown at 37-C in 5% CO2 in 50-ml conical Falcon polypropylene tubes (Falcon Labware, Oxnard, CA). 2 ml of media was replaced each day. The cells were used after 4-6 d when confluent.
Cell loading with indo-J. Indo-l AM was stored at -20'C as a 1 mM stock solution in dimethyl sulfoxide. Approximately 2 ml of suspended cell-covered microcarriers were used for one set of experiments.
Indo-1 AM was added to the medium at a final concentration of 5 gM, and the cells were returned to their incubator for 30-60 min. The microcarrier suspension was then poured into a 5-ml syringe fitted with 111 m polyethylene Spectra/Mesh (Spectrum Medical Industries, Los Angeles, CA), which allowed the medium containing unincorporated indo-l AM and any dead or unattached cells to drain through while retaining the cell-covered microcarriers. The microcarriers retained on the mesh were then washed rapidly with 25 ml of Hanks' balanced salt solution containing 25 mM Hepes (HBSS), suspended in 0.5 ml of HBSS containing 1% human albumin, and maintained at room temperature until used. The washed, indo-l-loaded cells were used within 1-2 h, during which time they remained viable, responsive, and attached to the microcarriers. Dye leakage during the course of these experiments never exceeded 8%. The intracellular indo-l concentration after the above loading procedure was estimated to be 60-200 tM, based on an average cell density of 50,00.0/cm2 and an estimated endothelial cell volume of 1.5 pl (22, 23) .
Fluorescence measurements. Aliquots of indo-1-loaded cells attached to microcarriers were added to 2 ml of HBSS in a stirred, temperaturecontrolled (370C) cuvette in the spectrofluorometer (SLM 8000, SLMAminco, Urbana, IL). The excitation wavelength was 355 nm with a 16-nm slit width. Crossed polarizers were used throughout to minimize the effects oflight scattering. The indo-1 emission was monitored as the ratio of intensities recorded at 400/480 nm, using two double-grating emission monochromators (16-nm slit widths) placed in T format. Hamamatsu Corp. R928P photomultiplier tubes (Middlesex, NJ) in cooled housings were employed on both emission channels. Emission spectra were recorded with 4-nm slit widths and were corrected for the wavelengthdependent response of the photomultiplier tubes.
Roughly 5-10 ,l of settled microcarriers (about 2,000 beads) containing 2-3 cm2 surface area and 100,000-200,000 cells were used for each experiment. Therefore, one umbilical cord in 5 d yielded cells for about 20-30 experiments. The fluorescence data in the figures are each representative of experiments performed four or more times in different cell isolates.
Calcium calibration. The fluorescence recorded from the indo-lloaded microcarrier-cell suspensions was found to be significantly affected by contributions from both the Raman peak and the intrinsic fluorescence of the endothelial cells (see Fig. 1 ). Thus, the equation developed by Grynkiewicz et al. (24) could not be used to calculate cytosolic calcium directly from the recorded ratio of400/480-nm emission intensities. Accordingly, calibration of the 400/480-nm emission (obtained under the conditions of these experiments) to the cytosolic free-calcium concentration ([Ca2`]J) was performed empirically as follows: after dye loading, cell-covered microcarriers were washed and suspended in the cuvette by methods described above, except calcium-free HBSS containing 10 mM EGTA was substituted for HBSS. lutions of indo-1 were unaffected by addition of digitonin (not shown). vWF immunoassay. vWF antigen was quantitated using a modification of the enzyme-linked immunosorbent assay described by Fishman et al. (27) . Microtiter plates were first coated with a goat anti-human factor VIII-related antigen (Atlantic Antibodies, Scarborough, ME), followed by incubation with test sample. The second antibody was an affinity-purified rabbit antibody to human vWF prepared in our laboratory and verified to be monospecific on Western blots ofwhole human plasma, human endothelial cell conditioned media, and endothelial cell detergent lysates. In control experiments, we confirmed that there is negligible binding of this antibody to bovine vWF (present in unconditioned culture medium). This rabbit antibody was followed by F(ab)2 fragments ofgoat anti-rabbit IgG conjugated to alkaline phosphatase (Sigma Chemical Co.). Finally, the alkaline phosphatase substrate used was p-nitrophenol phosphate 1 mg/ml in 0.1 M glycine, pH 10.4, with 1 mM MgCI2 and 1 mM ZnC12. Dilutions of normal plasma pooled from five donors were used as the standards, and results are expressed as units per milliliter where I U is defined as the concentration of vWF in 1 ml of normal pooled plasma. The assay is linear in the range from 0.01 to 0.001 U. All samples were assayed in triplicate.
v WF release experiments. Cells were grown on 24-well tissue culture plates (2 cm2 per well) and used at confluence (5-6 d). Monolayers were washed three times with 37°C HBSS, and 0.4 ml of medium or HBSS containing the appropriate stimulus and/or antagonist was added. The cells were then incubated at 37°C for 45 min, and the medium was removed, centrifuged for 4 min in a Beckman microcentrifuge to remove cell debri, and the supernatants stored at -20°C until assayed. The monolayer was washed once with 1 ml of HBSS, and cell protein was assayed by the method of Lowry (28) using bovine albumin as a standard. Released vWF was expressed in units (as defined above) per milligram of total cell protein and compared with control wells in the same experiment. Results are reported as percent difference from control.
Cell cytotoxicity assay. Nonspecific cell toxicity was assessed by measuring release of [3H]deoxy-D-glucose (29) . Cells grown in 0.5-cm2 wells were incubated for 18 h with 0.1 ml of medium containing 1 LCi of [3H]DOG (15 Ci/mmol). Wells were then washed five times with 0.1 ml of HBSS-0.5% human albumin, and incubated for 45 min with histamine (10-3 to 10-8 M) or medium alone. After histamine treatment, the media was removed, and the wells were washed twice with 0.1 ml of HBSS with albumin. The cell monolayer was dissolved in 0.3 ml of 2% Triton X-100. Media and washes were pooled, and counted in 4 ml of Aquasol-2 in a Beckman LS98 beta counter (Beckman Instruments, Inc., Palo Alto, CA) with an efficiency of 36%; this count was designated released disintegrations per minute (R). Solubilized cells were similarly counted and designated cell-associated disintegrations per minute (C). Percent release was calculated as [R/(R + C)] X 100. Mean release at each histamine concentration (six replicates) was compared with the mean of 12 control wells containing no histamine, and is reported as percent difference from control.
Data analysis. vWF and [3H]DOG release data were analyzed using a standard one-and two-way analysis of variance (30) . Differences in mean release from cells in different treatment groups (different histamine doses, histamine and/or histamine antagonists, and histamine in the presence or absence of EGTA) were compared by computing multiple t confidence intervals (reference 30, page 80). To achieve an overall confidence level of 95%, the t statistic, t[l -a/2m, a(n -1)], was used to compute each interval, where a = 0.05, m = number of pairs of treatment groups being compared, a = total number of treatment groups, and n = number of replicates in each group. Changes in [Ca2"], in response to thrombin To maximize our ability to detect dynamic changes in [Ca2+Jc, the ratio of the high-and low-calcium peaks of indo-1 (400/480 nm) was continuously monitored using two emission monochrometers in T format. In Fig. 2 , changes in cytosolic calcium in response to selected concentrations of human thrombin are shown. The threshold dose at which a detectable change in fluorescence was reliably observed was 0.01 U/nil. Higher doses resulted in a higher peak [Ca2J]c, shorter time to peak, and a more prolonged response. The cells responded a second time to thrombin at the lower doses, but could not be restimulated after exposure to 1 U/ml thrombin ( Fig. 2 C) . Usually the [Ca2J]c did not return completely to baseline during the subsequent 5-10 min of observation, although this ability to recover from thrombin varied from one cell preparation to another. When the experiment was performed in 10 mM EGTA (Fig. 2 C) , the baseline ratio was lower and progressively declined (suggesting zII -a. DIP-thrombin, equivalent to 1 U/ml before inactivation, was added at arrow 1. Active thrombin (0.1 U/ml final concentration) was added at arrow 2. The effect of another active-site inhibitor of thrombin is shown in E. PPACK (final concentration 1.7 X 101 M) was added at arrow 1, followed by thrombin (1 U/ml) at arrow 2 and histamine (10-M) at arrow 3.
progressive leeching ofcalcium and/or loss ofdye from the cells).
Nevertheless, thrombin stimulated a marked rise in [Ca2`],, even in the presence of subnanomolar extracellular Ca2" (Fig. 2 C) .
Thrombin interacts with endothelial cells through several sites, including the active site, a heparin-like binding site, and thrombomodulin (1, 31, 32 (Fig. 2 D) . Thus it appears that active thrombin is required for generation of the calcium transient in endothelial cells, and that the enzyme with its active site blocked probably does not function as a competitive antagonist. The participation of the active site was confirmed using another thrombin inhibitor, PPACK. PPACK added to the cuvette at 1.7 X 10-6 M completely inhibited susequent activation of the cells by thrombin (1 U/ml) (Fig. 2 E) . The addition of PPACK after thrombin did not blunt the response or increase the rate of return of [Ca2+] , toward baseline (data not shown). The histamine response (described below) was not affected by PPACK (Fig. 2 E) , indicating that PPACK does not alter cell activation by other agonists.
The effects of other serine proteases on endothelial cell calcium were also evaluated, for comparison with thrombin. Plasmin was found to have no immediate effect on endothelial cell
[Ca2+]c when evaluated at the molar concentrations which gave peak thrombin response (10-8 M) , but caused a slow rise in
[Ca2+]c at 10-20-fold higher concentrations (Fig. 3 A) . We have observed cell detachment from culture flasks at these higher concentrations, probably due to digestion of cell adhesion proteins by plasmin. Nevertheless, these plasmin-treated cells remained responsive to thrombin (Fig. 3 A) . Urokinase alone had no effect on intracellular calcium (at concentrations up to 100 Committee on Thrombolytic Agents [CTA] U/ml, data not shown). In contrast to plasmin, trypsin induced an immediate rise in [Ca2+]c (Fig. 3 B) . Also, in contrast to the largely reversible changes in [Ca2+]c observed in response to thrombin, cells exposed to trypsin exhibited a sustained elevation of [Ca2+]c, suggesting that cells trypsinized from their adherent surface undergo pronounced changes in calcium homeostasis. In addition, a 5-min exposure to trypsin resulted in loss of 4%-8% of the fluorescent dye from the cells, which was insufficient to account for the observed ratio change but which suggests some cell membrane injury. It is ofinterest to note that the response illustrated in Fig. 3 (Fig. 5 C) . The peak increase in cytosolic calcium occurred within 15-30 s of histamine stimulation and was followed by partial recovery over 1-2 min and then a rather stable sustained phase ofelevated [Ca?+Jc (Fig. 4 D) . The calcium concentrations achieved during the rapid initial peak and during the sustained phase ofthe response were each dependent on the histamine dose (Fig. 4) . The histamine concentrations at which calcium transients were observed would appear to be physiologically relevant: serum Higher doses of histamine (10-4 and 10-3 M) resulted in slightly less vWF secretion, although these responses varied from experiment to experiment and did not differ significantly (P > 0.05) from the response to 10-5 M. As noted above, the peak [Ca2+], was also usually recorded at 10-M histamine, and a decline at higher histamine concentrations was frequently, but not always, observed (compare Figs. 4 D and 5 C). At 10-8 M histamine (the threshold dose at which a change in indo-l fluorescence was consistently detected), vWF release exceeded control levels by an average of45%. Histamine-induced vWF release occurred both in medium containing fetal bovine serum and in serumfree medium. No cell detachment or morphologic changes were observed by phase-contrast microscopy even at the highest dose tested (not shown). vWF secretion in response to histamine was not affected by preloading the cells with indo-I under the conditions used for measurement of [Ca2+],: indo-l-loaded cells released 0.103±0.017 U/ng of cell protein; control cells 0.096±0.14 U/ng (mean±SD, n = 6). The release of vWF from histamine-treated endothelial cells was accompanied by a slight increase in the efflux of [3HJDOG from the cells. Nevertheless, the effilux ofthis trapped aqueous marker was small in magnitude when compared with the concomitant release of vWF (cf. Fig.  5, A and B) , suggesting that the observed histamine-induced release ofvWF cannot be attributed simply to nonspecific membrane leakage.
The time course of histamine-induced vWF secretion is shown in Fig. 6 and is compared with secretion in response to the calcium ionophore A23187 (both agonists at 10-5 M). vWF release was detectable within 1 min of histamine stimulation (data now shown), and 25% oftotal release in these experiments occurred within the first 3 min (Fig. 6) (Fig. 4) . Of interest, the magnitude and time course of secretion in response to histamine are similar to that induced by the calcium ionophore.
Contribution of sequestered intracellular Ca"'. In order to determine the contribution of intracellular calcium stores to the observed rise in [Ca2+J0 in response to histamine, the microcarrier-bound cells were suspended in buffer containing 10 mM EGTA (to chelate external calcium) and then stimulated with histamine. As previously shown for thrombin ( Fig. 2 C above) , an elevation of [Ca2+JL was observed upon exposure to histamine, even in the presence of 10 mM external EGTA (Fig. 4 C) (Fig. 8) . These observations implicate the HI receptor in calcium messenger generation in these cells (consistent with the original definition of HI receptor) and suggest that pyrilamine has a much higher affinity for the endothelial HI-receptor than histamine itself. The pyrilamine block is nevertheless reversible, and could be overcome by increasing the histamine concentration 100-fold (Fig. 8 C) .
Histamine caused a dose-dependent elevation in cytosolic calcium which never returned to baseline during any 15-min experiment (cf. Fig. 4 D) (Fig. 9 A), which returned [Ca2"], to baseline. This is in contrast to the thrombin-induced increase in cytosolic Ca2", which was not reversed by removal of thrombin from the medium (data not shown).
The effect of these specific HI-and H2-receptor antagonists on histamine-induced vWF secretion is shown in Fig. 10 . Consistent with the histamine-induced changes in [Ca2+]C observed in the presence of these drugs, histamine-stimulated vWF secretion was 85% inhibited by the Hi-receptor antagonist pyrilamine and was only 5% inhibited by cimetidine, when histamine and antagonist were used in equimolar concentrations. Neither antagonist significantly altered release of vWF from control cells not exposed to histamine.
Discussion
Advantages ofmicrocarrier-bound cell monolayers influorescent calcium indicator studies. Alteration of cytosolic calcium concentration is one mechanism by which extracellular agonists can activate or inactivate selected cellular processes (for reviews, see references 35 and 36) . Indirect evidence has suggested such a calcium second messenger might be important in a number of endothelial cell responses, including induction of PGI2 and PAF synthesis, vWF secretion, and mitogenesis. For example, it has been previously shown that calcium ionophores will triggerand EGTA abolish or diminish-some of these responses (34, 37) and that many agonists which cause endothelial cell proliferation (including thrombin and histamine) increase 45Ca2+ flux across the plasma membrane of these cells (4) . The fluorescent calcium indicators such as indo-1 (24) offer the opportunity to monitor [Ca2"], in cells which are relatively undisturbed except for the selected stimulus. Nevertheless, application of these probes to the study of anchorage-dependent cells such as endothelial cells has been limited, because of the need to obtain homogeneous cell suspensions for fluorescence measurements with readily available instrumentation.
Anchorage-dependent cells can be trypsinized from their attachment site to form suspensions for fluorescence studies (19, 20, 38) . However, the changes in [Ca2"], we observed in cells exposed to this protease (Fig. 3) suggest that significant disruption of calcium homeostasis occurs during proteolytic detachment and thus limits extrapolation of observations made on such cells to the physiologic responses of the unperturbed endothelium. By contrast, use of microcarriers permits study of these cells (23, 40, 41) . With the latter method, only a small, static field containing a single layer of cells is actually in the path of the exciting beam, resulting in a low signal-to-noise ratio, and increasing the artifacts ofindicator photobleaching and cell phototoxicity. Furthermore, in our experience, human endothelial cells adhere poorly to glass surfaces and detach with minimal shear stress (e.g., rinsing, stirring). Although digital imaging systems for fluorescence microscopy offer an alternative approach to quantitative monitoring of fluorescence from cell monolayers (42) , this instrumentation is not widely available, and permits sampling of only a small field of adherent cells.
The advantages of indo-l and related tetracarboxylate stilbene fluorophores for the measurement of cell calcium have been discussed in detail by Grynkiewicz et al. (24) . Our selection of indo-I for use in endothelial cells was based on the following considerations: in preliminary experiments comparing indo-1 with quin2, the higher signal-to-noise ratio obtainable with indo-1 permitted detection of Ca2+ transients at the low histamine concentrations employed in these experiments (e.g., threshold for detection of a quin2 response was 10-6 M histamine, whereas responses were reliably observed with indo-1 at 10-8 M histamine, Fig. 5 C) The most striking effect of histamine in vivo is an increase in vascular permeability, particularly in postcapillary venules. Disruption of interendothelial cell junctions by histamine has been repeatedly described (10, 11) and is felt to be the cellular basis for the permeability change. We now demonstrate that histamine induces characteristic changes in the [Ca2"]c of this cell (Fig. 4) (Fig. 4 C) (Figs. 5 C and 9) . These results suggest (a) that histamine binding to its endothelial HI-receptor is freely reversible, and (b) that the sustained phase ofthe histamine response requires continued receptor occupancy. One might speculate that the rapid reversibility of histamine-stimulated elevation of [Ca2+] , enables the endothelium to respond rapidly to changes in local histamine concentration, especially in that histamine-induced permeability changes have also been shown to reverse shortly after removal of histamine (10) .
The histamine-induced rise in cytosolic Ca2' in human endothelial cells was accompanied by secretion of vWF. Although our data suggest that calcium may be an important triggering event in secretion, studies of other cell types indicate that histamine binding to its HI receptor stimulates turnover of membrane phosphatidylinositol (44) . Thus, other intracellular events (in particular activation of protein kinase C) are likely to play a role in histamine-induced secretion. Only three agents have previously been shown to induce exocytosis ofstored vWF from cultured endothelial cells (thrombin, calcium ionophore, and the phorbol ester, 4-phorbol 12-myristate 13-acetate) (6, 34, 37) and only one of these (thrombin) is of potential physiologic significance in vivo. We have now demonstrated that histamine, an important modulator of endothelial function in vivo, induces vWF secretion from human endothelial cells in culture. Furthermore, histamine simultaneously triggers both endothelial cell retraction with exposure of subendothelium (predominantly in postcapillary venules), and release ofthe plasma protein (vWF) required for platelet adhesion to subendothelium at the high shear rates existing in the microcirculation (45, 46) . The potential significance of this stimulated release of vWF to platelet deposition occurring at sites ofinflammation remains to be explored.
